Recurrent furunculosis: A review of the literature

British Journal of Dermatology

Volumn 167, Issue 4, 2012, Pages 725-732

  Demos, M ^a   McLeod, M P ^a   Nouri, K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

FURUNCULOSIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN ABSCESS; STAPHYLOCOCCUS AUREUS; UNITED KINGDOM;

BACTERIAL TOXINS; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; FURUNCULOSIS; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RECURRENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 84867003395     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11151.x     Document Type: Review

References (86)

1. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
2. Dissemond J,. Methicillin resistant Staphylococcus aureus (MRSA): diagnostic, clinical relevance and therapy. J Dtsch Dermatol Ges 2009; 7: 544-51; quiz 552-3.
3. Maguire GP, Arthur AD, Boustead PJ, et al. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164: 721-3.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 278: 593-8.
5. Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001; 40: 1-4.
6. Tan HH, Tay YK, Goh CL,. Bacterial skin infections at a tertiary dermatological centre. Singapore Med J 1998; 39: 353-6.
7. Purcell K, Fergie JE,. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2002; 21: 988-9.
8. Seal JB, Moreira B, Bethel CD, et al. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol 2003; 24: 403-8.
9. Nimmo GR, Bell JM, Mitchell D, et al. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999. Microb Drug Resist 2003; 9: 155-60.
10. Nimmo GR, Coombs GW,. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 2008; 31: 401-10.
11. Millar BC, Loughrey A, Elborn JS, et al. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007; 67: 109-13.
12. David MZ, Daum RS,. Community-associated methicillin-resistant Staphyolococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-87.
13. Jansen WT, Beitsma MM, Koeman CJ, et al. Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 2072-8.
14. Coombs GW, Monecke S, Pearson JC, et al. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol 2011; 11: 215.
15. Fang H, Hedin G, Li G, et al. Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005. Clin Microbiol Infect 2008; 14: 370-6.
16. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40: 4289-94.
17. Gonzalez BE, Rueda AM, Shelburne SA 3rd, et al. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006; 27: 1051-6.
18. Elston JW, Barlow GD,. Community-associated MRSA in the United Kingdom. J Infect 2009; 59: 149-55.
19. Hersh AL, Chambers HF, Maselli JH, Gonzales R,. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585-91.
20. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008; 51: 291-8.
21. Orscheln RC, Hunstad DA, Fritz SA, et al. Contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis 2009; 49: 536-42.
22. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005; 45: 311-20.
23. Magilner D, Byerly MM, Cline DM,. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J 2008; 69: 351-4.
24. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74.
25. Gladstone GP, Van Heynigen WE,. Staphylococcal leukocidins. Br J Exp Pathol 1957; 38: 123-37.
26. Cribier B, Prévost G, Couppie P, et al. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992; 185: 175-80.
27. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-32.
28. Del Giudice P, Blanc V, de Rougemont A, et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 2009; 219: 299-302.
29. Del Giudice P, Bes M, Hubiche T, et al. Panton-Valentine leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infections. Dermatology 2011; 222: 167-70.
30. Masiuk H, Kopron K, Grumann D, et al. Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus. J Clin Microbiol 2010; 48: 1527-35.
31. Durupt F, Mayor L, Bes M, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol 2007; 157: 1161-7.
32. Prevost G, Couppie P, Prevost P, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995; 42: 237-45.
33. Couppie P, Cribier B, Prévost G,. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994; 130: 1208-9.
34. Young LM, Price CS,. Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis. Surg Infect (Larchmt) 2008; 9: 469-74.
35. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-53.
36. Akpaka PE, Monecke S, Swanston WH, et al. Methicillin sensitive Staphylococcus aureus producing Panton-Valentine leukocidin toxin in Trinidad & Tobago: a case report. J Med Case Rep 2011; 5: 157.
37. Yamasaki O, Kaneko J, Morizane S, et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005; 30: 381-5.
38. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194: 1761-70.
39. Varshney AK, Martinez LR, Hamilton SM, et al. Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. J Infect Dis 2010; 201: 92-6.
40. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, et al. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198: 1166-70.
41. Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13: 1405-6.
42. Brown EL, Dumitrescu O, Thomas D, et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus U.S.A.300. Clin Microbiol Infect 2009; 15: 156-64.
43. Diep BA, Palazzolo-Ballance AM, Tattevin P, et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008; 3: e3198.
44. Kobayashi SD, DeLeo FR,. An update on community-associated MRSA virulence. Curr Opin Pharmacol 2009; 9: 545-51.
45. Lo WT, Wang CC,. Panton-Valentine leukocidin in the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Pediatr Neonatol 2011; 52: 59-65.
46. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39: 971-9.
47. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-24.
48. Del Giudice P, Bes M, Hubiche T, et al. Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin- resistant Staphylococcus aureus clone ST80-IV. J Eur Acad Dermatol Venereol 2011; 25: 164-9.
49. Robert J, Tristan A, Cavalie L, et al. Panton-Valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008. Antimicrob Agents Chemother 2011; 55: 1734-9.
50. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184: 384-8.
51. Kanerva M, Salmenlinna S, Vuopio-Varkila J, et al. Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006. J Clin Microbiol 2009; 47: 2655-7.
52. Francois P, Harbarth S, Huyghe A, et al. Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland. Emerg Infect Dis 2008; 14: 304-7.
53. Otter JA, French GL,. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. Clin Microbiol Infect 2008; 14: 670-6.
54. Rossney AS, Shore AC, Morgan PM, et al. The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J Clin Microbiol 2007; 45: 2554-63.
55. Laurent F, Lelièvre H, Cornu M, et al. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001; 47: 277-83.
56. Health Protection Agency. Community MRSA in England and Wales: definition through strain characterisation. Commun Dis Rep CDR Wkly 2005; 15: 3-4.
57. Holmes A, Ganner M, McGuane S, et al. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005; 43: 2384-90.
58. Kearns AM, Rathmann IM, Holmes A, et al. An unusual clone of MRSA causing injection drug user-related sepsis. J Infect 2004; 49: 49-50.
59. Kearns AM, Ganner M, Hill RLR, et al. Community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales. Presented at the 17th European Congress of Clinical Microbiology and Infectious Diseases. Munich, Germany, 31 March to 4 April 2007.
60. David MD, Kearns AM, Gossain S, et al. Community-associated methicillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect 2006; 64: 244-50.
61. Health Protection Agency. Hospital-associated transmission of Panton-Valentine leukocidin (PVL) positive community associated MRSA in the West Midlands. Commun Dis Rep CDR Wkly 2006; 16: 1-2.
62. Green SM, Marsh P, Ahmad N, et al. Characterization of community and hospital Staphylococcus aureus isolates in Southampton, U.K. J Med Microbiol 2010; 59: 1084-8.
63. Habif TP,. Bacterial infections. In: Clinical Dermatology (, Bonnett C, ed), 5th edn. Oxford: Mosby, 2010; 356-8.
64. Kars M, van Dijk H, Salimans MM, et al. Association of furunculosis and familial deficiency of mannose-binding lectin. Eur J Clin Invest 2005; 35: 531-4.
65. Emonts M, Uitterlinden AG, Nouwen JL, et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 2008; 197: 1244-53.
66. Gilad J, Borer A, Smolyakov R, et al. Impaired neutrophil functions in the pathogenesis of an outbreak of recurrent furunculosis caused by methicillin-resistant Staphylococcus aureus among mentally retarded adults. Microbes Infect 2006; 8: 1801-5.
67. Hamaliaka A, Novikova I,. Nitric oxide production disorders in leukocytes of patients with recurrent furunculosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154: 163-7.
68. Demirçay Z, Ekşioǧlu-Demiralp E, Ergun T, Akoǧlu T,. Phagocytosis and oxidative burst by neutrophils in patients with recurrent furunculosis. Br J Dermatol 1998; 138: 1036-8.
69. Higashi O, Sato Y, Takamura H, Oyama M,. Mean cellular peroxidase (MCP) of leukocytes in iron-deficiency anemia. Tohoku J Exp Med 1967; 93: 105-13.
70. Prasad JS,. Leucocyte function in iron-deficiency anemia. Am J Clin Nutr 1979; 32: 550-2.
71. Weijmer MC, Neering H, Welten C,. Preliminary report: furunculosis and hypoferraemia. Lancet 1990; 336: 464-6.
72. Dahl MW,. Strategies for the management of recurrent furunculosis. South Med J 1987; 80: 352-6.
73. El-Gilany AH, Fathy H,. Risk factors of recurrent furunculosis. Dermatol Online J 2009; 15: 16.
74. Levine N,. Solitary, enlarging red lesion on upper back. Patient appears fine otherwise, except for Crohn's disease. Geriatrics 2005; 60: 16.
75. Pérez-Roth E, Alcoba-Flórez J, López-Aguilar C, et al. Familial furunculosis associated with community-acquired leukocidin-positive methicillin-susceptible Staphylococcus aureus ST152. J Clin Microbiol 2010; 48: 329-32.
76. Landen MG, McCumber BJ, Asam ED, et al. Outbreak of boils in an Alaskan village: a case-control study. West J Med 2000; 172: 235-9.
77. Williams RE,. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71.
78. Hedström SA,. Recurrent staphylococcal furunculosis. Bacteriological findings and epidemiology in 100 cases. Scand J Infect Dis 1981; 13: 115-19.
79. Guzik TJ, Bzowska M, Kasprowicz A, et al. Persistant skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005; 35: 448-55.
80. Nolte O, Haag H, Zimmerman A, et al. Staphylococcus aureus positive for Panton-Valentine leukocidin genes but susceptible to methicillin in patients with furuncles. Eur J Clin Microbiol Infect Dis 2005; 24: 477-9.
81. Ohana N, Keness J, Verner E, et al. Skin-isolated, community-acquired Staphylococcus aureus: in vitro resistance to methicillin and erythromycin. J Am Acad Dermatol 1989; 21: 544-6.
82. Bartlett PC, Martin RJ, Cahill BR,. Furunculosis in a high school football team. Am J Sports Med 1982; 10: 371-4.
83. Sosin DM, Gunn RA, Ford WL, et al. An outbreak of furunculosis among high school athletes. Am J Sports Med 1989; 17: 828-32.
84. Müller-Premru M, Strommenger B, Alikadic N, et al. New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team. Eur J Clin Microbiol Infect Dis 2005; 24: 848-50.
85. Embil JM, Oliver ZJ, Mulvey MR, Trepman E,. A man with recurrent furunculosis. CMAJ 2006; 175: 143.
86. Wiese-Posselt M, Heuck D, Draeger A, et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 2007; 44: e88-95.